These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8122693)

  • 1. Comparison of concurrent and retrospective methods of detecting adverse drug reactions.
    Madsen JJ
    Am J Hosp Pharm; 1993 Dec; 50(12):2556-7. PubMed ID: 8122693
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of pharmacy-based concurrent surveillance and medical record retrospective reporting of adverse drug reactions.
    Schumock GT; Thornton JP; Witte KW
    Am J Hosp Pharm; 1991 Sep; 48(9):1974-6. PubMed ID: 1928145
    [No Abstract]   [Full Text] [Related]  

  • 3. Computer-assisted use of tracer antidote drugs to increase detection of adverse drug reactions: a retrospective and concurrent trial.
    Dalton-Bunnow MF; Halvachs FJ
    Hosp Pharm; 1993 Aug; 28(8):746-9, 752-5. PubMed ID: 10127575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of clinical pharmacy services in a community hospital.
    Williams LE
    Hosp Pharm; 1993 Aug; 28(8):759-63, 766-7. PubMed ID: 10127576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adverse-drug-reaction-reporting system at a teaching hospital in India.
    Mohan N; Rao PG; Rao G
    Am J Health Syst Pharm; 2003 Mar; 60(5):486-7. PubMed ID: 12635458
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacy-coordinated, multidisciplinary adverse drug reaction program.
    Swanson KM; Landry JP; Anderson RP
    Top Hosp Pharm Manage; 1992 Jul; 12(2):49-59. PubMed ID: 10136574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An ADR surveillance program: increasing quality, number of incidence reports.
    Orsini MJ; Orsini PA; Thorn DB; Gallina JN
    Formulary; 1995 Aug; 30(8):454-61. PubMed ID: 10151733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction monitoring program in a community hospital.
    Cramer RL; Sketo DV; Greene JL; Wright CA
    Am J Hosp Pharm; 1992 Mar; 49(3):627-9. PubMed ID: 1598942
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacy services provided to an emergency department.
    Laivenieks N; McCaul K; O'Brodovich M
    Can J Hosp Pharm; 1992 Jun; 45(3):113-5. PubMed ID: 10119691
    [No Abstract]   [Full Text] [Related]  

  • 11. New pharmacy processes implemented at a community teaching hospital.
    Stevenson WT
    Am J Health Syst Pharm; 2003 Mar; 60(6):575-7. PubMed ID: 12659061
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription errors and the impact of computerized prescription order entry system in a community-based hospital.
    Jayawardena S; Eisdorfer J; Indulkar S; Pal SA; Sooriabalan D; Cucco R
    Am J Ther; 2007; 14(4):336-40. PubMed ID: 17667207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Culture counts--sustainable inpatient computerized surveillance across Duke University Health System.
    Cozart H; Horvath MM; Long A; Whitehurst J; Eckstrand J; Ferranti J
    Qual Manag Health Care; 2010; 19(4):282-91. PubMed ID: 20924248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical service differences between teaching and community hospitals.
    Baumgardner KP; Kabat HF
    Hosp Pharm; 1992 Dec; 27(12):1073, 1077-80, 1085-8. PubMed ID: 10122511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Justification and evaluation of an aminoglycoside pharmacokinetic dosing service.
    Jorgenson JA; Rewers RF
    Hosp Pharm; 1991 Jul; 26(7):605, 609-11, 615. PubMed ID: 10111793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking a policy on nonformulary drugs to the FDA's therapeutic-potential classification system.
    Poirier TI; Vorbach M; Bache T
    Am J Hosp Pharm; 1994 Sep; 51(18):2277-8. PubMed ID: 7801989
    [No Abstract]   [Full Text] [Related]  

  • 17. A successful community hospital program for monitoring adverse drug reactions.
    Saine DR
    Top Hosp Pharm Manage; 1992 Jul; 12(2):19-30. PubMed ID: 10128726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishing a more formal adverse drug reaction reporting system.
    Tse CS; Madura AJ
    Hosp Formul; 1992 Aug; 27(8):845-8. PubMed ID: 10119518
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased adverse drug reaction reporting through wall-mounted ADR reporting cards.
    Szymusiak-Mutnick BA; Ross MB
    Formulary; 1995 Aug; 30(8):471-3. PubMed ID: 10151735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adverse drug reaction: a clinical opportunity for pharmacists.
    Miller JD
    Hosp Pharm; 1995 Sep; 30(9):769-73. PubMed ID: 10151281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.